GLP1R and obesity due to melanocortin 4 receptor deficiency: Testosterone replacement should be beneficial in men with low testosterone levels according to current guidelines; assessment of androgen status, including individuals with low or borderline testosterone levels frequently observed in obesity, may be clinically relevant when evaluating patients experiencing substantial weight loss with GLP-1-based therapies.